We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Haleon | LSE:HLN | London | Ordinary Share | GB00BMX86B70 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.70 | -0.18% | 378.10 | 376.90 | 377.10 | 380.00 | 376.00 | 377.40 | 7,147,785 | 16:35:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Offices-holdng Companies,nec | 11.3B | 1.05B | 0.1148 | 32.84 | 34.6B |
Date | Subject | Author | Discuss |
---|---|---|---|
30/11/2022 18:56 | Anyone have any insight into when GSK and PFE will have liquidated their holdings here? | rikky72 | |
16/11/2022 11:47 | PPE Please stop posting this rubbish, or back it up with evidence! Trying to find some should keep you off this site for a while. | mercedes | |
16/11/2022 10:06 | There isn't any, it's total puff! | ianood | |
16/11/2022 09:46 | Evidence please on that statement. | grahamburn | |
16/11/2022 05:17 | Pfizer are already dumping shares since the overhang was lifted in November after Haleon rejects requests for indemnifications on Zantac. Pfizer needing to build a cash position to fund the over 2,000 tort legal cases pending in the Florida state court in mid 2023..A further 51 state courts litigations are also in the pipeline with global litigation in other non US jurisdictions pending. GSK likely to follow suite with exiting its Haleon holdings to fund Zantac litigation costs. | paul planet earth | |
11/11/2022 10:09 | These two stocks look like a good match to me :-) | richie1218 | |
10/11/2022 16:39 | My blood pressure is synchronised with the crashing share price ! | abdullla | |
10/11/2022 16:12 | I worry for your blood pressure, you seem to follow every rise and fall of the share price like you were personally hitching a ride on it.. :O | rikky72 | |
10/11/2022 14:43 | Crashing big time | abdullla | |
10/11/2022 12:20 | I was reading that JNJ are also planning to float off their consumer health division. | spacecake | |
10/11/2022 09:36 | Generally encouraging Q3 update today. Happy to continue holding on these figures. | anhar | |
09/11/2022 12:26 | Okay thanks | timothyo6 | |
07/11/2022 13:48 | FWIW... 27th oct Kepler hold tp 275p 14th oct Jefferies hold tp 280p 7th sept JP Morgan underweight tp 250p 16th aug RBC sect perform tp 300p 29th july Deutsche hold tp 300p 21st july Citigroup buy tp 360p 20th july BOA buy tp 385p 20th july Goldmans buy tp 350p 19th july UBS buy tp 380p 19th july Credit Suisse outperform tp 353p 19th july Barclays equal weight tp 347p | philanderer | |
14/10/2022 08:58 | I have no idea of the future share price of HLN but it's odd how the price has been rising lately in view of your repeated bearish comments. If you really are interested in what brokers and press etc. think, you need to check out all of them and see what the balance of their opinion is, not just cherry pick those that agree with your predetermined view. That's called confirmation bias and is one of the large range of classic small investor mistakes. I personally have no interest in such views but make up my own mind, which is that on balance HLN is more worth keeping than selling now. | anhar | |
12/10/2022 03:55 | 'Wallet Investor’s Haleon long-term forecast indicated that the stock could be a non-viable investment. The algorithm-based forecasting service predicted that the share price could fall to £2.21 by the end of 2022 and decline throughout 2023 to trade at just £0.09 by the end of the year. The stock could effectively fall to zero by 2024, according to WalletInvestor&rsquo The Haleon stock 5-year forecast from Gov Capital similarly estimated that the American Depositary Receipts (ADRs) for Haleon listed in the US could drop to zero, but by November 2023.' The most likely scenario is that due to the impact of generic drug labels, rising consumer inflation, and multi billion dollar Zantac litigation costs and settlements the share price will fall. The high burden of existing debt, rising interest rates, and flattening consumer sales reflected in the falling share price, note the price is down 16% since floatation with the expected off loading of both Pfizer and GSK's share holdings in November places more downward pressure on the share price on the foreseeable future. | paul planet earth | |
11/10/2022 13:40 | Haleon sales targets impress Barclays Bank has a 347p target on the Sensodyne, Panadol and Centrum owner | zho | |
08/10/2022 06:47 | HALEON PLC LON: HLN OverviewNewsCompareF 281.25 GBX -27.10 (-8.79%)past 1 month 7 Oct, 17:49 BST • Disclaimer | paul planet earth | |
07/10/2022 09:54 | PPE Please check the facts.......Its a bargain at these price levels | mercedes | |
07/10/2022 09:31 | Strange how the share has been rising in recent weeks, given that the lock-in overhang from GSK and PFE is public knowledge and has been ever since the demerger details were released months ago. I don't have the faintest idea of the manner in which they might dispose of their HLN shares and how it might affect the share price, but it just seems odd that if you are correct with your repetitive assertions about a price crash driven by big sales, why would the price be rising now? Big cap share prices are driven by institutional trading, small private investors like us are irrelevant. So the rising price must be driven by inst buying on balance. Why would that be if it is feared that the price would soon collapse? Surely, if your view proves anywhere near accurate, they would be better waiting for the big HLN price crash you keep mentioning. In other words their opinions must be virtually the exact opposite of yours. I''m not saying that insts are always right, they're often wrong, but it does appear odd in this situation where there's only a few weeks at stake. My view is that any potential big price fall is already in the price so there is little to fear. In any case, personally I hold shares very long term so I'm hanging on to my HLN allocation as it may prove to be a good share in years to come. Short term fears like you keep stating are of no concern to me and even if you're right, I'd see it as a buying opportunity and nothing to worry about. Nobody is going to care in several years time about a historical GSK/PFE overhang. | anhar | |
03/10/2022 11:20 | Not long now till Pfizer and GSK both dump their 45% stakes in November after being told by Halitosis to get stuffed over Zantac indemnities..Just watch that share price dive in December..😅& | paul planet earth | |
03/10/2022 09:57 | My thought also, weak GBP, is this going to get gobbled up ? | spacecake | |
29/9/2022 16:55 | Is some one stake building? One of the very few companies that is actually up. | netcurtains | |
27/9/2022 17:37 | I repeat, a gift at this price. | mercedes | |
27/9/2022 11:36 | HALEON PLC LON: HLN OverviewNewsCompareF 281.70 GBX −4.65 (1.62%)today 27 Sept, 12:36 BST • Disclaimer | paul planet earth |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions